FDA approves jaw joint prosthetic developed by University of Pennsylvania

	Tweet

After a 10-year clinical trial of a jaw joint replacement developed by Peter Quinn of the University of Pennsylvania School of Dental Medicine, the Food and Drug Administration has given it a thumbs-up.

Because of almost ceaseless motion a human jaw moves about 700,000 times a year as a person chews, talks, swallows and yawns the jaw, or temporomandibular joint, can become a problem for as many as 20 million Americans, said Quinn, chairman of oral and maxillofacial surgery at Penn Dental Medicine. Teeth grinding and injuries also take their toll.

“Temporomandibular disease is almost a uniquely female disease. Almost 90 percent of the people in the trial were female, and most had TMD as a result of slippage of a disc in the joint,” Quinn said. “TMD in male patients is mostly due to injury.”

"What we set out to do was get approval for a stock prosthesis,” said Quinn, whose stock device is the first in history to get FDA approval through a rigorous pre-market approval process.

In 1991, Quinn paired with an orthopedic company called Biomet to design the appliance and do the requisite materials testing. Biomet later acquired a maxillofacial surgical company, W. Lorenz Surgical Inc., and the prosthesis is marketed as the Lorenz TMJ replacement system. The clinical trials got under way in 1995 at Penn, where 75 percent of the surgeries were performed, and Southwestern University in Georgetown, Texas, which accounted for the rest. The trials involved 285 patients and 403 joints. Both joints were replaced in some patients.

Quinn’s TMJ prosthesis is constructed of the materials found in the more common knee and hip replacements, a polyethylene socket and a cobalt-chromium-molybdenum alloy ball, which avoids s high wear-rate problems but presents other challenges, such as its mechanics. Unlike knees and hips, the jaw moves differently by coming out of the socket, and each joint contains a disc that can slip or wear down. Also, it is much harder to fit a stock prosthesis in the jaw since the bone structure doesn allow much room.

“The socket is only a millimeter or two from your brain, is very thin in the middle and has this bump that differs from person to person,” Quinn said. “So we flattened the design to eliminate the bump, created three different sizes and enabled the device to be screwed into the cheek bone.”

The Lorenz prosthesis is already approved for use at two sites in Canada and eight in Europe, where Quinn has trained the surgeons. There will be 12 to 20 sites in the U.S. and six in South America.

“We had an agreement with the FDA that it would be approved with the condition of training, so it couldn just be sold,” Quinn said. “You want surgeons who do enough of these since it is so technique sensitive. We are identifying surgeons who do a lot of TMJ surgery through the American Society of Temporomandibular Joint Surgery.”

Recuperation from the procedure takes four to six weeks.

http://www.upenn.edu

RELATED STORIES:
Study evaluates risk factors for chronic TMJD   Study will delve into oral health, memory link   Redheads especially fearful of dental pain   Dental amalgam not linked to ill effects in kids   Prevent periodontitis to reduce the risk of head and neck cancer   Gum, patches help reluctant quitters smoke less   New Process Could Improve Dental Restoration Procedures   Does tooth - brushing cause epilepsy seizures?   Scientists find shared genetic link between the dental disease periodontitis and heart attack   Type of lip piercing can cause receding gums   Program cuts cavities in low-income toddlers   Even Healthy Pregnant Women Need to Worry About Oral Bacteria

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]